Rakuten Medical - To conquer cancer.

Rakuten Medical Logo

Rakuten Medical Stories

Year Archive

    collapsArch options:
Array
(
    [title] => Year Archive
    [noTitle] => 
    [inExcludeCat] => exclude
    [inExcludeCats] => 
    [inExcludeYear] => exclude
    [inExcludeYears] => 
    [showPages] => 
    [sort] => DESC
    [linkToArch] => 1
    [showYearCount] => 
    [expandCurrentYear] => 1
    [expandMonths] => 
    [expandYears] => 
    [expandCurrentMonth] => 
    [showMonthCount] => 
    [showPostTitle] => 
    [expand] => 0
    [showPostDate] => 
    [debug] => 1
    [postDateFormat] => m/d
    [postDateAppend] => after
    [accordion] => 1
    [useCookies] => 1
    [post_type] => stories
    [taxoncmy] => category
    [postTitleLength] => 
    [showPostCount] => 1
    [style] => custom
    [archSortOrder] => DESC
    [showPosts] => 
    [customExpand] => 
    [customCollapse] => 
    [taxonomy] => both
    [so_sidebar_emulator_id] => collapsarch-729710003
    [option_name] => widget_collapsarch
    [panels_info] => Array
        (
            [class] => collapsArchWidget
            [raw] => 
            [grid] => 1
            [cell] => 1
            [id] => 3
            [widget_id] => 89715525-396f-4351-b0e2-b3fc707eb06b
            [style] => Array
                (
                    [class] => year-archive
                    [background_image_attachment] => 
                    [background_display] => tile
                )

            [cell_index] => 0
            [widget_index] => 3
        )

    [number] => 729710003
)
POST QUERY:
 SELECT wp_6_terms.slug, wp_6_posts.ID,
    wp_6_posts.post_name, wp_6_posts.post_title, wp_6_posts.post_author,
    wp_6_posts.post_date, YEAR(wp_6_posts.post_date) AS 'year',
    MONTH(wp_6_posts.post_date) AS 'month' ,
    wp_6_posts.post_type
    FROM wp_6_posts LEFT JOIN wp_6_term_relationships ON wp_6_posts.ID =
    wp_6_term_relationships.object_id 
		LEFT JOIN wp_6_term_taxonomy ON wp_6_term_taxonomy.term_taxonomy_id =
																			wp_6_term_relationships.term_taxonomy_id
		LEFT JOIN wp_6_terms ON wp_6_terms.term_id = 
		                          wp_6_term_taxonomy.term_id 
  WHERE post_status='publish' AND wp_6_posts.post_type='stories'   
  GROUP BY wp_6_posts.ID 
  ORDER BY wp_6_posts.post_date DESC

POST QUERY RESULTS
Array
(
    [0] => stdClass Object
        (
            [slug] => rakuten-medical
            [ID] => 7088
            [post_name] => rakuten-medical-celebrates-its-10-year-anniversary
            [post_title] => Rakuten Medical celebrates its 10-year anniversary
            tfiliyas => 4
             => 2020-04-22 22:53:13
            [year] => 2020
            [month] => 4
            [post_type] => stories
        )

    [1] => stdClass Object
        (
            [slug] => rakuten
            [ID] => 7076
            [post_name] => a-decade-of-disruption-5-tech-storylines-set-to-define-2020-and-beyond
            [post_title] => A decade of disruption: 5 tech storylines set to define 2020 and beyond
            tfiliyas => 12
             => 2020-01-10 13:43:25
            [year] => 2020
            [month] => 1
            [post_type] => stories
        )

    [2] => stdClass Object
        (
            [slug] => investment
            [ID] => 7075
            [post_name] => 38th-annual-j-p-morgan-healthcare-conference
            [post_title] => 38th Annual J.P. Morgan Healthcare Conference
            tfiliyas => 14
             => 2020-01-10 10:22:25
            [year] => 2020
            [month] => 1
            [post_type] => stories
        )

    [3] => stdClass Object
        (
            [slug] => rakuten
            [ID] => 7077
            [post_name] => the-19-billion-dollar-startups-to-watch-that-are-revolutionizing-healthcare-in-2020
            [post_title] => The 19 billion-dollar startups to watch that are revolutionizing healthcare in 2020
            tfiliyas => 12
             => 2020-01-03 16:58:45
            [year] => 2020
            [month] => 1
            [post_type] => stories
        )

    [4] => stdClass Object
        (
            [slug] => amsterdam
            [ID] => 7073
            [post_name] => in-the-wake-of-brexit-amsterdam-is-the-new-london
            [post_title] => In the Wake of Brexit, Amsterdam Is the New London
            tfiliyas => 12
             => 2019-12-02 17:34:58
            [year] => 2019
            [month] => 12
            [post_type] => stories
        )

    [5] => stdClass Object
        (
            [slug] => rakuten
            [ID] => 7072
            [post_name] => top-10-immuno-oncology-startups-of-2019
            [post_title] => Top 10 Immuno-Oncology Startups of 2019
            tfiliyas => 12
             => 2019-12-02 17:31:51
            [year] => 2019
            [month] => 12
            [post_type] => stories
        )

    [6] => stdClass Object
        (
            [slug] => rakuten-medical
            [ID] => 7068
            [post_name] => rakuten-anti-cancer-therapy-candidate-to-activate-immune-system-response
            [post_title] => Rakuten anti-cancer therapy candidate to activate immune system response
            tfiliyas => 12
             => 2019-11-18 14:41:08
            [year] => 2019
            [month] => 11
            [post_type] => stories
        )

    [7] => stdClass Object
        (
            [slug] => rakuten
            [ID] => 7063
            [post_name] => walk-together-rakuten-ceo-shares-vision-for-the-future-at-rakuten-optimism-in-san-francisco
            [post_title] => WALK TOGETHER: RAKUTEN CEO SHARES VISION FOR THE FUTURE AT RAKUTEN OPTIMISM IN SAN FRANCISCO
            tfiliyas => 12
             => 2019-11-11 15:26:10
            [year] => 2019
            [month] => 11
            [post_type] => stories
        )

    [8] => stdClass Object
        (
            [slug] => rakuten-medical
            [ID] => 7069
            [post_name] => rakuten-medical-releases-new-post-hoc-analysis-of-safety-pharmacokinetic-pk-immunogenicity-and-biomarker-data-from-its-phase-1-1-2a-clinical-trials
            [post_title] => Rakuten Medical Releases New, Post-hoc Analysis of Safety, Pharmacokinetic (PK), Immunogenicity and Biomarker Data from its Phase 1 & 1/2a Clinical Trials
            tfiliyas => 12
             => 2019-11-05 14:43:37
            [year] => 2019
            [month] => 11
            [post_type] => stories
        )

    [9] => stdClass Object
        (
            [slug] => 2019
            [ID] => 7053
            [post_name] => jefferies-2019-london-healthcare
            [post_title] => Jefferies 2019 London Healthcare Conference
            tfiliyas => 12
             => 2019-11-04 16:22:43
            [year] => 2019
            [month] => 11
            [post_type] => stories
        )

    [10] => stdClass Object
        (
            [slug] => life
            [ID] => 7052
            [post_name] => investival-showcase
            [post_title] => Investival Showcase
            tfiliyas => 12
             => 2019-11-04 16:18:35
            [year] => 2019
            [month] => 11
            [post_type] => stories
        )

    [11] => stdClass Object
        (
            [slug] => cancer
            [ID] => 7050
            [post_name] => sitc-annual-meeting-2019
            [post_title] => SITC Annual Meeting 2019
            tfiliyas => 12
             => 2019-11-01 14:02:54
            [year] => 2019
            [month] => 11
            [post_type] => stories
        )

    [12] => stdClass Object
        (
            [slug] => rakuten-medical
            [ID] => 7046
            [post_name] => rakuten-medical-to-further-develop-its-photoimmunotherapy
            [post_title] => Rakuten Medical to further develop its photoimmunotherapy
            tfiliyas => 12
             => 2019-10-26 21:05:02
            [year] => 2019
            [month] => 10
            [post_type] => stories
        )

    [13] => stdClass Object
        (
            [slug] => rakuten
            [ID] => 7045
            [post_name] => rakuten-medical-extends-series-c-treatment-by-100m
            [post_title] => Rakuten Medical extends series C treatment by $100m
            tfiliyas => 12
             => 2019-10-26 21:02:37
            [year] => 2019
            [month] => 10
            [post_type] => stories
        )

    [14] => stdClass Object
        (
            [slug] => rakuten-medical
            [ID] => 7044
            [post_name] => ecommerce-company-rakuten-invests-100-million-in-rakuten-medical-increasing-equity-share-to-22-5
            [post_title] => Ecommerce Company Rakuten Invests $100 Million in Rakuten Medical, Increasing Equity Share to 22.5%
            tfiliyas => 12
             => 2019-10-26 21:01:12
            [year] => 2019
            [month] => 10
            [post_type] => stories
        )

    [15] => stdClass Object
        (
            [slug] => rakuten-medical
            [ID] => 7043
            [post_name] => rakuten-medical-secures-additional-investment-from-rakuten
            [post_title] => Rakuten Medical secures additional investment from Rakuten
            tfiliyas => 12
             => 2019-10-26 20:59:11
            [year] => 2019
            [month] => 10
            [post_type] => stories
        )

    [16] => stdClass Object
        (
            [slug] => 
            [ID] => 7042
            [post_name] => at-newly-rechristened-rakuten-medical-japanese-billionaire-mikitani-ups-the-ante-with-another-megaround
            [post_title] => At newly rechristened Rakuten Medical, Japanese billionaire Mikitani ups the ante with another megaround
            tfiliyas => 12
             => 2019-10-26 20:57:08
            [year] => 2019
            [month] => 10
            [post_type] => stories
        )

    [17] => stdClass Object
        (
            [slug] => rakuten-medical
            [ID] => 7041
            [post_name] => rakuten-medical-reels-in-another-megaround-to-fund-cancer-rd
            [post_title] => Rakuten Medical reels in another megaround to fund cancer R&D
            tfiliyas => 12
             => 2019-10-26 20:54:06
            [year] => 2019
            [month] => 10
            [post_type] => stories
        )

    [18] => stdClass Object
        (
            [slug] => tumors
            [ID] => 7039
            [post_name] => u-s-clinical-trial-light-therapy-kills-cancer-cells-in-4-of-30-patients
            [post_title] => U.S. clinical trial: Light therapy kills cancer cells in 4 of 30 patients
            tfiliyas => 12
             => 2019-10-26 20:48:37
            [year] => 2019
            [month] => 10
            [post_type] => stories
        )

    [19] => stdClass Object
        (
            [slug] => rakuten
            [ID] => 7038
            [post_name] => online-retailer-rakutens-biotech-offices-in-taiwan-amsterdam-to-speed-up-anti-cancer-drug-development
            [post_title] => Online retailer Rakuten’s biotech offices in Taiwan, Amsterdam to speed up anti-cancer drug development
            tfiliyas => 12
             => 2019-10-26 20:46:49
            [year] => 2019
            [month] => 10
            [post_type] => stories
        )

    [20] => stdClass Object
        (
            [slug] => rakuten-medical
            [ID] => 7037
            [post_name] => rakuten-medical-opens-european-headquarters-in-the-netherlands
            [post_title] => Rakuten Medical Opens European Headquarters in the Netherlands
            tfiliyas => 12
             => 2019-10-26 20:44:56
            [year] => 2019
            [month] => 10
            [post_type] => stories
        )

    [21] => stdClass Object
        (
            [slug] => pit
            [ID] => 7036
            [post_name] => rakuten-medical-releases-phase-2a-study-data-during-asco-annual-meeting-highlighting-positive-safety-profile-and-clinically-meaningful-anti-tumor-activity
            [post_title] => Rakuten Medical Releases Phase 2a Study Data during ASCO Annual Meeting Highlighting Positive Safety Profile and Clinically Meaningful Anti-tumor Activity
            tfiliyas => 12
             => 2019-10-26 20:40:31
            [year] => 2019
            [month] => 10
            [post_type] => stories
        )

    [22] => stdClass Object
        (
            [slug] => rakuten
            [ID] => 7035
            [post_name] => rakuten-medical-opens-two-new-offices-as-it-expands-global-presence
            [post_title] => Rakuten Medical opens two new offices as it expands global presence
            tfiliyas => 12
             => 2019-10-26 20:38:48
            [year] => 2019
            [month] => 10
            [post_type] => stories
        )

    [23] => stdClass Object
        (
            [slug] => cancer
            [ID] => 7034
            [post_name] => japan-approves-rakuten-medicals-asp-1929-to-treat-cancer
            [post_title] => Japan approves Rakuten Medical's ASP-1929 to treat cancer
            tfiliyas => 12
             => 2019-10-26 20:36:29
            [year] => 2019
            [month] => 10
            [post_type] => stories
        )

    [24] => stdClass Object
        (
            [slug] => rakuten
            [ID] => 7032
            [post_name] => rakutens-ceo-is-developing-a-brilliant-new-cancer-treatment-light
            [post_title] => Rakuten’s CEO Is Developing a Brilliant New Cancer Treatment: Light
            tfiliyas => 12
             => 2019-10-25 16:00:38
            [year] => 2019
            [month] => 10
            [post_type] => stories
        )

    [25] => stdClass Object
        (
            [slug] => cancer
            [ID] => 7029
            [post_name] => nih-licenses-cancer-killing-near-ir-photoimmunotherapy-to-startup
            [post_title] => NIH licenses cancer-killing near-IR photoimmunotherapy to startup
            tfiliyas => 12
             => 2019-10-25 15:46:41
            [year] => 2019
            [month] => 10
            [post_type] => stories
        )

    [26] => stdClass Object
        (
            [slug] => bio
            [ID] => 7051
            [post_name] => bio-investor-forum-san-francisco
            [post_title] => BIO Investor Forum
            tfiliyas => 12
             => 2019-10-13 14:09:26
            [year] => 2019
            [month] => 10
            [post_type] => stories
        )

    [27] => stdClass Object
        (
            [slug] => oncology
            [ID] => 7049
            [post_name] => esmo-congress-2019-2
            [post_title] => ESMO Congress 2019
            tfiliyas => 12
             => 2019-09-30 13:57:48
            [year] => 2019
            [month] => 9
            [post_type] => stories
        )

    [28] => stdClass Object
        (
            [slug] => oncology
            [ID] => 7047
            [post_name] => asco-annual-meeting-2019
            [post_title] => ASCO Annual Meeting 2019
            tfiliyas => 12
             => 2019-06-01 11:58:58
            [year] => 2019
            [month] => 6
            [post_type] => stories
        )

    [29] => stdClass Object
        (
            [slug] => cancer
            [ID] => 7020
            [post_name] => near-infrared-light-kills-cancer-builds-immune-response
            [post_title] => Near-infrared light kills cancer, builds immune response
            tfiliyas => 13
             => 2019-02-13 10:00:23
            [year] => 2019
            [month] => 2
            [post_type] => stories
        )

)
  • 2020
  • 2019

Related Content

People
×
Innovation
×
Action
×
A Note from Our Chairman

In 2012, my father was diagnosed with pancreatic cancer. I was ready to do anything for him to be cured. With that sole purpose, I read many scientific papers from all over the world, and I met and talked with numerous experts in the field. How could I cure my father’s cancer? I searched every single possibility available.

That is when I found out about photoimmunotherapy that was only at an early stage of research. Although I had many doubts about this completely new approach, desperate for a miracle, I immediately went to meet the researcher.

Everyone was still doubtful at that stage. But the more I heard about this research, the more it made sense. 

I instinctively thought, “This is it.” It was the same feeling I got as when I grasped that the internet would change the world forever. Somehow, wishing to save my father, I immediately made up my mind to support the research personally to speed it up.

Unfortunately, we didn’t make it in time to save my father. But I decided to continue my support. My father who was as an economist always said, “One important mission of corporations is to contribute to humanity.”

Left behind, I resolved to provide this latest treatment to as many people as possible. It will surely be a path fraught with difficulties. But right at this moment there are many who are suffering from cancer, many who wish to save the lives of their loved ones, and I know exactly how they feel.

To provide this treatment as soon as possible, to bring this treatment to as many people as possible, I will not fail to support this research from now on.

Chairman, Rakuten Medical, Inc.

Hiroshi Mikitani

×